Invictus' Acreage Pharms Awarded Sales License

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

VANCOUVER, May 18, 2018

VANCOUVER, May 18, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage Pharms") has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR) effective May 18, 2018.

Aerial Image of Acreage Pharms Phase 1 and Phase 2 (CNW Group/Invictus MD Strategies)

Dan Kriznic, Invictus Chairman and CEO commented, "We are thrilled to have obtained our sales license from Health Canada. This is the crowning milestone in our licensing journey for Invictus, as we march towards fulfilling capacity goals during this historic and important year for Canada's cannabis industry. We started this company in 2014 with the intention of becoming Canada's Cannabis Company. With the granting of Acreage Pharms' sales license and the completion of the Phase 2 structure at Acreage Pharms, two key milestones in the drive towards that intent now have been achieved. This dramatically advances our timeline for increasing our annual run-rate production capacity at our current 39,600 square foot facilities and construction plan for the 80,000 square foot Phase 3 to be completed by September 2018 in time for the adult-use market."

The awarding of the license coincides with the launch of Invictus' extensive retail development plan, an ongoing effort that hinges on the ownership and opening of at least 20 dispensaries in British Columbia, Alberta and Saskatchewan; supply agreements with governmental bodies and licensed producers; and securing large-scale product calls and supply agreements, as well as smaller "craft" agreements.

With an emphasis on a refined consumer experience — Invictus stores will offer shopping experiences evocative of Canada's natural beauty, with natural woods, open floor plans, tasteful lighting, and iPad-wielding sales associates deeply trained in cannabis —Invictus dispensaries will stand apart. Acreage Pharms', which cultivates and manufactures high-quality cannabis products, is an essential part of the retail strategy.

Acreage Pharms anchors 150 acres of convertible land in Alberta, and is poised to support the cannabis industry and its community with a safe product that is well-researched, lab-tested and distributed through regulated channels. Increasing Invictus' canopy footprint has been a sharp focus of the company, as beginning in the middle of 2018 Canada's demand rises for high-quality, pesticide-free product for both the current medical cannabis market and the adult market once legalized.

"This is the crowning jewel that we all have been working towards since 2013, and wonderful news," said Acreage Pharms founder and CEO Tervor Dixon. "Our team has worked tirelessly, and with immense savvy and commitment to detail, to make this happen. Without all of their hard work, day after day, this crowning achievement would remain merely a dream, rather than a reality. Our seed-to-sale model is now complete in the medical arena, and our client service team is ready to serve customers in the recreational retail sector, including dispensaries owned by Acreage Pharms' corporate parent, Invictus. With so many medical patients signing-up for care every month, more and more now turn to Acreage Pharms client service team for assistance in securing our high-quality cannabis. We all look forward to serving many more consumers in months and years to come."

ARIVA.DE Börsen-Geflüster

Kurse

Invictus MD Strategies

0,00%

Added Kriznic: "Regulators and lawmakers, community advocates and the business community across Canada have been working hard to build the sturdiest, safest and most sensible legal cannabis industry in the world. Invictus is honored to take part in these historic efforts."

About Invictus

Invictus owns and operates two cannabis production sites under the ACMPR in Canada with the vision of producing a variety of high quality and low cost cannabis products and strains to the global market place as regulations permit. The Company's wholly owned subsidiary Acreage Pharms is located in West-Central Alberta. Invictus also owns 50% of AB Laboratories Inc. ("AB Labs") located in Hamilton, Ontario. During the first quarter of 2018 AB Labs submitted a secondary license to Health Canada for a nearby property on 100 acres under the name AB Ventures Inc. ("AB Ventures").

Recently the Company announced that it has entered into a binding letter of intent for an option to acquire 100% of the outstanding shares of an applicant (the "OptionCo") the ACMPR.

Combined, the licensed producers owned by Invictus expect to have approximately 327,000 square feet of cannabis production capacity by the end of 2018 and 817,000 square feet of cannabis production capacity by the end of 2019.

Gene Simmons, music legend and media mogul, conveys the vision of Invictus as the Chief Evangelist Officer.

Invictus owns 100% of Poda and its related intellectual property, the world's first zero-cleaning vaporizer system. Poda's fully biodegradable pods are self-contained, and do not contaminate the vaporizer with odor, flavor and residue.

In addition to the ACMPR licenses, the Company has an 82.5% investment in Future Harvest Development Ltd. a high quality Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia that has been in operation for over 20 years under the brand Plant Life Products and Holland Secret.

Invictus' Canadian Production Footprint:

			Square Footage
Company	Phase	Province	Current	31-Dec-18	31-Dec-19
Acreage Pharms	1	Alberta	7,000	7,000	7,000
Acreage Pharms	2	Alberta	33,000	33,000	33,000
Acreage Pharms	3	Alberta		80,000	80,000
Acreage Pharms	4	Alberta			240,000
Total Acreage Pharms			40,000	120,000	360,000
AB Laboratories	1	Ontario	16,000	16,000	16,000
AB Laboratories	2	Ontario		40,000	40,000
Total AB Laboratories			16,000	56,000	56,000
AB Ventures	1	Ontario		21,000	21,000
AB Ventures	2	Ontario		80,000	80,000
Total AB Ventures			-	101,000	101,000
Option Co	1	British Columbia		50,000	50,000
Option Co	2	British Columbia			250,000
Total Option Co			-	50,000	300,000
Total Combined			56,000	327,000	817,000

For more information, please visit www.invictus-md.com.

On Behalf of the Board,
Dan Kriznic
Chairman & CEO

Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676

Mehr Nachrichten zur Invictus MD Strategies Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.